Literature DB >> 11876738

Helping to understand studies examining genetic susceptibility to sepsis.

S Nadel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876738      PMCID: PMC1906326          DOI: 10.1046/j.1365-2249.2002.01781.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  Interpretation of results from genetic studies of multifactorial diseases.

Authors:  J A Todd
Journal:  Lancet       Date:  1999-07       Impact factor: 79.321

Review 2.  Cytokines and anticytokines in the pathogenesis of sepsis.

Authors:  T van der Poll; S J van Deventer
Journal:  Infect Dis Clin North Am       Date:  1999-06       Impact factor: 5.982

3.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

4.  High Susceptibility of Strain A Mice to Endotoxin and Endotoxin-Red Blood Cell Mixtures.

Authors:  G Heppner; D W Weiss
Journal:  J Bacteriol       Date:  1965-09       Impact factor: 3.490

5.  Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.

Authors:  A D O'Brien; D L Rosenstreich; I Scher; G H Campbell; R P MacDermott; S B Formal
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

Review 6.  Genetic dissection of the molecular pathogenesis of severe infection.

Authors:  D Kwiatkowski
Journal:  Intensive Care Med       Date:  2000       Impact factor: 17.440

7.  Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis.

Authors:  F Arnalich; D López-Maderuelo; R Codoceo; J Lopez; L M Solis-Garrido; C Capiscol; C Fernandez-Capitán; R Madero; C Montiel
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

8.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Authors:  C J Fisher; J F Dhainaut; S M Opal; J P Pribble; R A Balk; G J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

  10 in total
  1 in total

Review 1.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.